Planning Stage

策划阶段

基本信息

项目摘要

We expect the initial planning stage to be relatively succinct as there is already an established history of discussions, meetings, and collaborative efforts between the SBCC and personnel from Fresno State. The Co- Principal Investigators (Junn and Vuori) and Co-Program Directors (Bush and Salvesen), other members ofthe Internal Advisory Committee (Rogerson, Calderon-Urrea, Ronai, Alfred), and participating faculty from both institutions have been communicating since our first submission in April 2007 for the purpose of planning and wrriting this application. As we have made changes to personnel and addressed reviewer's comments, we have done in a team spirit¿through dialogue and mutual agreement. The leadership and organizational structure of the Pao has already been established. The follovring activities will be conducted during the initial planning stage: ¿ Founding of the administrative core, hiring of the Program Coordinator at Fresno State and delegating an administrative assistant at SBCC. ¿ A one-day scientific retreat will be held at Fresno State, SBMRI, or a common mutual location (Los Angeles). The follovdng participants will be requested to attend the retreat: o The P20 leadership, including the Co-PIs, Co-PDs, and the IAC members o The EAC members (Drs. Alfred, Bayliss, Carson, Hudson) o Fresno State President, Dr. John Welty and Provost, Dr. Bill Covino o Other interested faculty from the College of Science and Math (primarily Biology and Chemistry departments) and the College of Health and Human Services of Fresno State o Dr. Paul Mills of UCSF-Fresno o Drs. Wolf and Pellecchia of the SBCC o Sanford-Burnham Medical Research Institute President/CEO, Dr. John Reed o Drs. Capitman and Ruwe of the Central Valley Health Policy Institute o Other interested faculty from the Sanford-Burnham Medical Research Institute ¿ The initial meetings of the IAC will be held, with the venue alternating between SBMRI and Fresno State. LAC meetings will occur monthly during the initial planning and priority-setting phases of the P20, then quarterly during the implementation stage. ¿ The External Advisory Committee (EAC) will have its first meeting. The meeting will be convened at Fresno State. The EAC will meet annually thereafter. ¿ Drs. Bush and Krishnan and their SBCC collaborators will present their projects to the IAC and EAC for review and, based on the feedback received, will finalize the details of their research projects. ¿ Fresno State CAMP, EOP, LSAMP, McNair, HCOP undergraduate and Biology/Chemistry Master's students will be notified of the training opportunities available to them in the P20 and Drs. Bush and Krishnan of Fresno State will hold an informational seminar for them along with Drs. Capitman and Ruwe ofthe CVHPL
我们希望最初的规划阶段相对简洁,因为已经有一个既定的历史

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KRISTIINA VUORI其他文献

KRISTIINA VUORI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KRISTIINA VUORI', 18)}}的其他基金

SENIOR LEADERSHIP
高层领导
  • 批准号:
    8378373
  • 财政年份:
    2012
  • 资助金额:
    $ 9.04万
  • 项目类别:
DEVELOPMENT FUNDS
发展基金
  • 批准号:
    8378379
  • 财政年份:
    2012
  • 资助金额:
    $ 9.04万
  • 项目类别:
HTS for Caspase-8 selective TRAIL Sensitizers
用于 Caspase-8 选择性 TRAIL 敏化剂的 HTS
  • 批准号:
    8262536
  • 财政年份:
    2011
  • 资助金额:
    $ 9.04万
  • 项目类别:
HTS for Caspase-8 selective TRAIL Sensitizers
用于 Caspase-8 选择性 TRAIL 敏化剂的 HTS
  • 批准号:
    8400429
  • 财政年份:
    2011
  • 资助金额:
    $ 9.04万
  • 项目类别:
Implementation Stage
实施阶段
  • 批准号:
    8180508
  • 财政年份:
    2010
  • 资助金额:
    $ 9.04万
  • 项目类别:
Planning Stage
策划阶段
  • 批准号:
    8180505
  • 财政年份:
    2010
  • 资助金额:
    $ 9.04万
  • 项目类别:
SENIOR LEADERSHIP
高层领导
  • 批准号:
    8181786
  • 财政年份:
    2010
  • 资助金额:
    $ 9.04万
  • 项目类别:
DEVELOPMENT FUNDS
发展基金
  • 批准号:
    8181789
  • 财政年份:
    2010
  • 资助金额:
    $ 9.04万
  • 项目类别:
Priority Stage
优先阶段
  • 批准号:
    8180507
  • 财政年份:
    2010
  • 资助金额:
    $ 9.04万
  • 项目类别:
Cell-based assay for high-throughput screening of TLR3 activators
基于细胞的 TLR3 激活剂高通量筛选分析
  • 批准号:
    7993022
  • 财政年份:
    2010
  • 资助金额:
    $ 9.04万
  • 项目类别:

相似海外基金

Advisory Committees
咨询委员会
  • 批准号:
    7353899
  • 财政年份:
    2006
  • 资助金额:
    $ 9.04万
  • 项目类别:
Toward a Political Theory of Bioethics: Participation, Representation, and Deliberation on Federal Bioethics Advisory Committees
迈向生命伦理学的政治理论:联邦生命伦理学咨询委员会的参与、代表和审议
  • 批准号:
    0451289
  • 财政年份:
    2005
  • 资助金额:
    $ 9.04万
  • 项目类别:
    Standard Grant
Advisory Committees
咨询委员会
  • 批准号:
    7557224
  • 财政年份:
  • 资助金额:
    $ 9.04万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    7902286
  • 财政年份:
  • 资助金额:
    $ 9.04万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    7691385
  • 财政年份:
  • 资助金额:
    $ 9.04万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    8150373
  • 财政年份:
  • 资助金额:
    $ 9.04万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了